DE3784939T2 - Molekulare klonierung und human b lymphotropischer virus klon (hblv). - Google Patents

Molekulare klonierung und human b lymphotropischer virus klon (hblv).

Info

Publication number
DE3784939T2
DE3784939T2 DE8787905817T DE3784939T DE3784939T2 DE 3784939 T2 DE3784939 T2 DE 3784939T2 DE 8787905817 T DE8787905817 T DE 8787905817T DE 3784939 T DE3784939 T DE 3784939T DE 3784939 T2 DE3784939 T2 DE 3784939T2
Authority
DE
Germany
Prior art keywords
hblv
human
clone
molecular cloning
lymphotropic virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787905817T
Other languages
English (en)
Other versions
DE3784939D1 (de
Inventor
Francis Josephs
C Gallo
Yeeching Wong-Staal
Zaki Salahuddin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Commerce
Original Assignee
US Department of Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Commerce filed Critical US Department of Commerce
Application granted granted Critical
Publication of DE3784939D1 publication Critical patent/DE3784939D1/de
Publication of DE3784939T2 publication Critical patent/DE3784939T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/705—Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16511—Roseolovirus, e.g. human herpesvirus 6, 7
    • C12N2710/16521—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16511—Roseolovirus, e.g. human herpesvirus 6, 7
    • C12N2710/16522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16511—Roseolovirus, e.g. human herpesvirus 6, 7
    • C12N2710/16551—Methods of production or purification of viral material
DE8787905817T 1986-08-12 1987-07-29 Molekulare klonierung und human b lymphotropischer virus klon (hblv). Expired - Lifetime DE3784939T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89585786A 1986-08-12 1986-08-12
PCT/US1987/001817 WO1988001305A1 (en) 1986-08-12 1987-07-29 Molecular cloning and clones of human b lymphotropic virus (hblv)

Publications (2)

Publication Number Publication Date
DE3784939D1 DE3784939D1 (de) 1993-04-22
DE3784939T2 true DE3784939T2 (de) 1993-07-08

Family

ID=25405191

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787905817T Expired - Lifetime DE3784939T2 (de) 1986-08-12 1987-07-29 Molekulare klonierung und human b lymphotropischer virus klon (hblv).

Country Status (8)

Country Link
EP (1) EP0321489B1 (de)
JP (1) JP2555118B2 (de)
AT (1) ATE87038T1 (de)
AU (1) AU615882B2 (de)
CA (1) CA1322342C (de)
DE (1) DE3784939T2 (de)
IL (1) IL83423A0 (de)
WO (1) WO1988001305A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE117022T1 (de) * 1987-06-01 1995-01-15 Baylor College Medicine Expression der immunoaktiven proteine von menschlichem b-lymphotropikvirus.
FR2651007B1 (fr) * 1989-08-18 1992-09-04 Pasteur Institut Fragments d'acides nucleiques et reactifs de diagnostic derives du genome de hhv6/sie et procede de diagnostic des infections a hhv6
JP2760896B2 (ja) * 1991-04-11 1998-06-04 シーダーズ―サイナイ・メディカル・センター ＨＩＶ特異的ＩｇＭの検出のための免疫検定

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237224A (en) * 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
JP2780020B2 (ja) * 1983-04-27 1998-07-23 プレジデント アンド フェロウズ オブ ハーバード カレッジ ヒトｔ細胞白血病ウイルス抗原及び該抗原を用いる検出方法
US4725669A (en) * 1984-11-09 1988-02-16 President And Fellows Of Harvard College Assay for detecting infection by human T-cell lymphotropic virus-III

Also Published As

Publication number Publication date
AU615882B2 (en) 1991-10-17
ATE87038T1 (de) 1993-04-15
JP2555118B2 (ja) 1996-11-20
IL83423A0 (en) 1988-01-31
WO1988001305A1 (en) 1988-02-25
EP0321489A1 (de) 1989-06-28
EP0321489A4 (en) 1991-03-13
DE3784939D1 (de) 1993-04-22
EP0321489B1 (de) 1993-03-17
CA1322342C (en) 1993-09-21
JPH02500326A (ja) 1990-02-08
AU7877387A (en) 1988-03-08

Similar Documents

Publication Publication Date Title
PT83434B (pt) Processo de preparacao de virus recombinantes, de peptidos ou proteinas e de vacinas contra o sindroma de imunodeficiencia adquirida
HUP0003911A2 (hu) Neoplazmák kezelése vírusokkal
DE3650175T2 (de) Synthetische antigene zum nachweis von aids.
FI934937A (fi) Sekvenser av hcv-genom foer diagnostisk och terapi
NO874750D0 (no) Bestemte dna-sekvenser avledet fra en papillomavirusgenom, deres bruk i in vitro diagnostikk og produksjon av antigene preparater.
ES2064077T3 (es) Integracion estable de adn en genomas bacterianos.
IE900854L (en) Immunogenic regions on the E7 protein of human¹papillomavirus type 16
AU7601887A (en) Expression products of human papilloma virus type 18, antibodies specific to these proteins, and diagnostic aids containing these antibodies or corresponding DNA
ATE68349T1 (de) Medizinische verwendung von nukleosiden.
SE8703225L (sv) Monoklonala antikroppar och peptider anvendbara vid behandling och diagnostisering av hiv-infektioner
DE3752170T2 (de) Synthetisches Antigen zum Nachweis von mit AIDS in Zusammenhang stehenden Krankheiten
CA2045323A1 (en) Non-a, non-b hepatitis virus genomic cdna and antigen polypeptide
DE69433007D1 (de) Peptide zum induzieren einer antwort der zytotoxischen t-lymphozyten gerichtet gegen das hepatitis b virus
DE3782867D1 (en) Human cytomegalovirus phospho-protein
DE3784939T2 (de) Molekulare klonierung und human b lymphotropischer virus klon (hblv).
DE3751772T2 (de) Impfstoff zur behandlung von hsv
DE68912155D1 (de) Antivirales Kombinationspräparat.
EE9400068A (et) Ravimsegud viirushepatiidi B (HBV) infektsiooni ja selle poolt p6hjustatud haiguste raviks ja nende valmistamise protsess
WO1996040764A3 (en) Nucleotide and amino acid sequences of hypervariable region 1 of the envelope 2 gene of hepatitis c virus
IT1285158B1 (it) Polipeptidi solubili con l'attivita' di serino-proteasi di ns3 del virus dell'epatite c, e procedimento per la loro preparazione e il
FI923020A (fi) Inte a inte b-sekvenser.
WO1998023752A3 (de) Papillomviren, mittel zu deren nachweis sowie zur therapie von durch sie verursachten erkrankungen
FI881123A (fi) Inaktivering av human immunodeficiency virus (hiv) medelst fenol i proteinhaltiga loesningar.
EP0370710A3 (de) DNS-Sequenz, die das Gen des Ueberzugsproteins vom Kartoffelblattroli-Virus kodiert
Skurkovich et al. Interferon-containing plasma: the preparation for treatment of viral infections